8-KThe WireRoutine
Bylaw Amendment
Filed Mar 4, 2026 · 3mo ago · Accession 0001104659-26-023467
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Liminatus Pharma, Inc.
- Ticker
- LIMNW
- CIK
- 1971387
- Form type
- 8-K
- Filing date
- Mar 4, 2026
- Report date
- Feb 27, 2026
- Document
- tm267974d1_8k.htm
- Size
- 407 KB